EMA Lapsed: Tritanrix HepB (Diphtheria toxoid;hepatitis B surface antigen;Bordetella pertussis (inactivated);tetanus toxoid) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

EMA status shows the Tritanrix HepB vaccine has lapsed and is no longer an active medicinal product in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Hepatitis B
• Tetanus
• Whooping Cough

Drugs mentioned

• Tritanrix-HepB (Diphtheria, Tetanus, and Hepatitis B vaccine (adsorbed))

Snippet

Status: Lapsed. Therapeutic area: Hepatitis B;Tetanus;Immunization;Whooping Cough;Diphtheria. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 01/01/2014